Pe1 recalls
The FDA has published 2 recalls involving Pe1 since 2023. The latest was reported on 1 Feb 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why pe1 is recalled
Companies
By year
All pe1 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pe1/papav/atrop/chloprom** 7mcg/8.7mg/0.1mg/1.8mg/ML Vial) recalled | Pharmacy Innovations | Sterility | Nationwide |
| Drug | CLASS II | Pe1/papav/phen 20mcg/30mg/2mg/ML Vial) Injectable recalled | Pharmacy Innovations | Sterility | Nationwide |
Should you stop taking Pe1?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.